These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34772407)

  • 21. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
    Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS
    PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
    Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
    Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats.
    Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K
    Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN-induced kinase 1-induced dynamin-related protein 1 Ser637 phosphorylation reduces mitochondrial fission and protects against intestinal ischemia reperfusion injury.
    Qasim W; Li Y; Sun RM; Feng DC; Wang ZY; Liu DS; Yao JH; Tian XF
    World J Gastroenterol; 2020 Apr; 26(15):1758-1774. PubMed ID: 32351292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy.
    Wang Y; Mao X; Chen H; Feng J; Yan M; Wang Y; Yu Y
    Int Immunopharmacol; 2019 Aug; 73():471-481. PubMed ID: 31170676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
    Chen Y; Huang Y; Xiong B; Luo H; Song X
    Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexmedetomidine attenuates hepatic ischemia-reperfusion injury-induced apoptosis via reducing oxidative stress and endoplasmic reticulum stress.
    Zhang S; Tang J; Sun C; Zhang N; Ning X; Li X; Wang J
    Int Immunopharmacol; 2023 Apr; 117():109959. PubMed ID: 36881980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation.
    Si Y; Bao H; Han L; Chen L; Zeng L; Jing L; Xing Y; Geng Y
    Br J Anaesth; 2018 Dec; 121(6):1260-1271. PubMed ID: 30442253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirtuin 3 is required for the dexmedetomidine-mediated alleviation of inflammation and oxidative stress in nephritis.
    Lu K; Li X; Wu J
    Immun Inflamm Dis; 2024 Jan; 12(1):e1135. PubMed ID: 38270316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms].
    Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury.
    Wang Z; Sun R; Wang G; Chen Z; Li Y; Zhao Y; Liu D; Zhao H; Zhang F; Yao J; Tian X
    Redox Biol; 2020 Jan; 28():101343. PubMed ID: 31655428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
    Wu ZL; Davis JRJ; Zhu Y
    Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
    Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
    Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats via Extracellular Signal-Regulated Kinase/Cyclic Adenosine Monophosphate Response Element Binding Protein Signaling Pathway.
    Teng L; Chen W; Yin C; Zhang H; Zhao Q
    World Neurosurg; 2019 Jul; 127():e624-e630. PubMed ID: 30930327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.
    Wang Z; Zhou W; Dong H; Ma X; He Z
    Mol Med Rep; 2018 Oct; 18(4):3957-3964. PubMed ID: 30106098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
    Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
    Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
    Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
    PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?
    Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O
    Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexmedetomidine inhibits endoplasmic reticulum stress to suppress pyroptosis of hypoxia/reoxygenation-induced intestinal epithelial cells via activating the SIRT1 expression.
    Liu X; Leng Y; Lv X; Lv J; Zhang M; Shi Y
    J Bioenerg Biomembr; 2021 Dec; 53(6):655-664. PubMed ID: 34586578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.